...
首页> 外文期刊>BMJ Open >Diagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study
【24h】

Diagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study

机译:可再现性胸壁压痛在急性胸痛中排除急性冠状动脉综合征的诊断性能:一项前瞻性诊断研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives Acute chest pain (ACP) is a leading cause of hospital emergency unit consultation. As there are various underlying conditions, ranging from musculoskeletal disorders to acute coronary syndrome (ACS), thorough clinical diagnostics are warranted. The aim of this prospective study was to assess whether reproducible chest wall tenderness (CWT) on palpation in patients with ACP can help to rule out ACS. Methods In this prospective, double-blinded diagnostic study, all consecutive patients assessed in the emergency unit at the University Hospital Zurich because of ACP between July 2012 and December 2013 were included when a member of the study team was present. Reproducible CWT on palpation was the initial step and was recorded before further examinations were initiated. The final diagnosis was adjudicated by a study-independent physician. Results 121 patients (60.3% male, median age 47?years, IQR 34–66.5?years) were included. The prevalence of ACS was 11.6%. Non-reproducible CWT had a high sensitivity of 92.9% (95% CI 66.1% to 98.8%) for ACS and the presence of reproducible CWT ruled out ACS (p=0.003) with a high negative predictive value (98.1%, 95% CI 89.9% to 99.7%). Conversely non-reproducible CWT ruled in ACS with low specificity (48.6%, 95% CI 38.8% to 58.5%) and low positive predictive value (19.1%, 95% CI 10.6% to 30.5%). Conclusions This prospective diagnostic study supports the concept that reproducible CWT helps to rule out ACS in patients with ACP in an early stage of the evaluation process. However, ACS and other diagnoses should be considered in patients with a negative CWT test. Trial registration number ClinicalTrial.gov: NCT01724996.
机译:目的急性胸痛(ACP)是医院急诊科咨询的主要原因。由于存在各种潜在的疾病,从肌肉骨骼疾病到急性冠状动脉综合征(ACS),因此需要进行全面的临床诊断。这项前瞻性研究的目的是评估ACP患者触诊时可重现的胸壁压痛(CWT)是否可以帮助排除ACS。方法在这项前瞻性,双盲的诊断研究中,包括2012年7月至2013年12月在苏黎世大学医院因ACP而在急诊室接受连续诊治的所有患者,均包括研究组成员。触诊时可重现的CWT是第一步,并在开始进一步检查之前进行记录。最终诊断由独立于研究的医生裁定。结果纳入121例患者(男性60.3%,中位年龄47岁,IQR 34-66.5岁)。 ACS的患病率为11.6%。不可重现的CWT对ACS的敏感性高达92.9%(95%CI为66.1%至98.8%),可重现的CWT排除了ACS(p = 0.003),具有较高的阴性预测值(98.1%,95%CI) 89.9%至99.7%)。相反,不可重现的CWT在ACS中具有低特异性(48.6%,95%CI 38.8%至58.5%)和低阳性预测值(19.1%,95%CI 10.6%至30.5%)。结论这项前瞻性诊断研究支持以下概念:可重现的CWT有助于在评估过程的早期排除ACP患者的ACS。但是,对于CWT测试阴性的患者,应考虑ACS和其他诊断。试用注册号ClinicalTrial.gov:NCT01724996。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号